Loading organizations...
Trancos Ventures operates as a venture capital firm, strategically partnering with nascent product innovators in the life sciences and cybersecurity sectors. The firm specializes in providing comprehensive support to companies developing high-risk products, aiming to transform their foundational concepts into successful market realities. Their core capabilities encompass intellectual property guidance, strategic marketing, product management, data analysis, manufacturing insight, and robust sales strategy development.
The origins of Trancos Ventures can be traced back to Vital Venture Capital, which served as its precursor, indicating an evolution or rebranding in its operational focus or structure. While specific founder names and the precise initiating insight are not readily available, this succession suggests a deliberate strategic refinement in its investment thesis and approach within the venture capital landscape.
Trancos Ventures primarily serves innovative entrepreneurs within the life sciences, health technology, and cybersecurity domains. The firm’s vision is to foster the growth of these early-stage companies, providing the necessary expertise and capital to navigate complex development cycles and market introductions. They are committed to empowering these enterprises to achieve significant impact in their respective fields.
Trancos Ventures has 1 tracked investment across 1 company. The latest tracked deal is $10.0M Series A in TARA Biosystems in June 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 1, 2020 | TARA Biosystems | $10.0M Series A | — | OMX Ventures, Alexandria Venture Investments, DEFTA Partners, LifeForce Capital, Merieux Equity Partners, NEW York Ventures, Partnership Fund For NEW York City, Tachyon Ventures |